NewGenIvf Group(NIVF)
$0.04-0.14 (-79.41%)
NIVF
NewGenIvf Group financials statements
$0.04
At close:-0.14 (-79.41%)
NewGenIvf Group (NIVF) Ratios
188 Followers
NewGenIvf Group Ratios
NIVF's free cash flow for Q4 2024 was $-6.36M. For the 2024 fiscal year, NIVF's free cash flow was decreased by $-2.82K and operating cash flow was $-6.35M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.12 | 1.17 | 2.19 | 1.83 | 0.40 |
| Quick Ratio | 2.98 | 1.14 | 2.08 | 0.90 | 0.38 |
| Cash Ratio | 0.32 | 0.17 | 0.05 | 1.09 | 0.01 |
| Solvency Ratio | 1.54 | -0.06 | 0.29 | 0.31 | 0.15 |
| Operating Cash Flow Ratio | -4.62 | -3.04 | -1.57 | -10.54 | 0.69 |
| Short-Term Operating Cash Flow Coverage | -42.67 | -14.19 | -8.27 | 0.00 | 2.79 |
| Net Current Asset Value | $ 647.50K | $ -1.89M | $ 1.22M | $ -2.37M | $ -1.51M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.15 | 0.85 | 0.07 | 0.01 | 0.66 |
| Debt-to-Equity Ratio | 0.18 | -2.89 | 0.09 | 0.01 | -1.19 |
| Debt-to-Capital Ratio | 0.15 | 1.53 | 0.08 | 0.01 | 6.17 |
| Long-Term Debt-to-Capital Ratio | 0.13 | 1.82 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.23 | -3.41 | 1.20 | 1.04 | -1.82 |
| Debt Service Coverage Ratio | 12.43 | 0.38 | 1.48 | 6.66 | 0.49 |
| Interest Coverage Ratio | -17.40 | -1.49 | 0.91 | -6.49 | 2.25 |
| Debt to Market Cap | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 335.39 | 6.47 | 7.46 | 10.44 | 19.99 |
| Net Debt to EBITDA | 0.38 | 106.02 | 0.72 | 0.55 | 1.53 |
| Profitability Margins | |||||
| Gross Profit Margin | 20.22% | 33.63% | 32.75% | 25.87% | 24.89% |
| EBIT Margin | 218.88% | -3.35% | 3.01% | 7.10% | 5.94% |
| EBITDA Margin | 229.45% | 0.45% | 7.48% | 12.21% | 14.25% |
| Operating Profit Margin | -226.95% | -21.35% | 0.82% | -8.49% | 4.83% |
| Pretax Profit Margin | 205.84% | -17.69% | 2.11% | 8.42% | 3.79% |
| Net Profit Margin | 209.02% | -9.66% | 2.53% | 7.72% | -0.01% |
| Continuous Operations Profit Margin | 205.84% | -8.72% | 2.11% | 2.29% | -3.36% |
| Net Income Per EBT | 101.55% | 54.63% | 120.08% | 91.61% | -0.34% |
| EBT Per EBIT | -90.70% | 82.84% | 256.66% | -99.16% | 78.58% |
| Return on Assets (ROA) | 30.19% | -14.67% | 2.90% | 0.65% | -0.04% |
| Return on Equity (ROE) | 37.10% | 50.07% | 3.49% | 0.67% | 0.07% |
| Return on Capital Employed (ROCE) | -35.34% | -135.29% | 1.26% | -0.71% | -30.43% |
| Return on Invested Capital (ROIC) | -34.77% | -32.65% | 1.11% | -0.42% | -1594.27% |
| Return on Tangible Assets | 102.09% | -14.67% | 2.90% | 0.65% | -0.04% |
| Earnings Yield | 25.35% | -0.00% | 0.01% | 0.03% | -0.00% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.42 | 2.30 | 9.89 | 2.56 | 5.49 |
| Payables Turnover | 4.84 | 2.78 | 20.01 | 42.10 | 65.91 |
| Inventory Turnover | 11.24 | 44.62 | 27.36 | 93.92 | 74.94 |
| Fixed Asset Turnover | 2.06 | 14.62 | 11.52 | 11.74 | 6.95 |
| Asset Turnover | 0.14 | 1.52 | 1.14 | 0.08 | 2.91 |
| Working Capital Turnover Ratio | 1.73 | 6.07 | 7.45 | -9.88 | 0.00 |
| Cash Conversion Cycle | 39.59 | 35.42 | 32.02 | 137.93 | 65.84 |
| Days of Sales Outstanding | 82.56 | 158.72 | 36.92 | 142.72 | 66.51 |
| Days of Inventory Outstanding | 32.46 | 8.18 | 13.34 | 3.89 | 4.87 |
| Days of Payables Outstanding | 75.44 | 131.48 | 18.24 | 8.67 | 5.54 |
| Operating Cycle | 115.02 | 166.90 | 50.27 | 146.60 | 71.38 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -668.67 | -14.05 | -34.80 | -10.39 | 28.24 |
| Free Cash Flow Per Share | -1020.55 | -14.14 | -36.18 | -12.25 | 27.91 |
| Dividend Paid and CapEx Coverage Ratio | -1.90 | -155.80 | -25.29 | -5.58 | 86.46 |
| Capital Expenditure Coverage Ratio | -1.90 | -155.80 | -25.29 | -5.58 | 86.46 |
| Operating Cash Flow Coverage Ratio | -2.25 | -2.73 | -5.31 | -1.17 | 1.55 |
| Operating Cash Flow to Sales Ratio | -2.31 | -1.52 | -0.34 | -0.09 | 0.35 |
| Free Cash Flow Yield | -42.80% | -0.06% | -0.11% | -0.04% | 0.09% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 3.94 | -1089.38 | 12745.65 | 3385.52 | -2807691.44 |
| Price-to-Sales (P/S) Ratio | 8.24 | 2630.98 | 323.09 | 261.24 | 363.40 |
| Price-to-Book (P/B) Ratio | 1.46 | -13631.44 | 444.21 | 22.73 | -1928.63 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -2.34 | -1718.64 | -903.82 | -2498.21 | 1056.53 |
| Price-to-Operating Cash Flow Ratio | -3.57 | -1729.67 | -939.56 | -2945.85 | 1044.31 |
| Price-to-Earnings Growth (PEG) Ratio | -0.00 | 3.90 | -159.11 | -0.00 | 0.00 |
| Enterprise Value Multiple | 3.97 | 589214.06 | 4318.60 | 2140.35 | 2550.88 |
| Enterprise Value | 43.07M | 14.30B | 1.66B | 1.55B | 1.50B |
| EV to EBITDA | 3.97 | 589214.06 | 4318.60 | 2140.35 | 2550.88 |
| EV to Sales | 9.11 | 2631.45 | 323.14 | 261.31 | 363.62 |
| EV to Free Cash Flow | -2.58 | -1718.95 | -903.97 | -2498.85 | 1057.16 |
| EV to Operating Cash Flow | -3.94 | -1729.98 | -939.72 | -2946.61 | 1044.94 |
| Tangible Book Value Per Share | 179.98 | -2.52 | 63.96 | 1346.34 | -18.03 |
| Shareholders’ Equity Per Share | 1629.84 | -1.78 | 73.61 | 1346.34 | -15.29 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.51 | 0.00 | 0.42 | 1.89 |
| Revenue Per Share | 289.26 | 9.24 | 101.21 | 117.13 | 81.15 |
| Net Income Per Share | 604.61 | -0.89 | 2.57 | 9.04 | -0.01 |
| Tax Burden | 1.02 | 0.55 | 1.20 | 0.92 | -0.00 |
| Interest Burden | 0.94 | 5.28 | 0.70 | 1.19 | 0.64 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 2.47 | 0.55 | 0.32 | 0.19 | 0.19 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -1.12 | 17.43 | -13.57 | -1.05 | -10.34 |
Currency in USD

